A Study of the Safety and Efficacy of MK-1293 Compared to Lantus™ in Participants With Type 1 Diabetes Mellitus (T1DM) (MK-1293-003)
Clinical trial NCT02059161 · COMPLETED
Trial details
- NCT number
- NCT02059161
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-17
- Primary completion
- 2015-05-04
- Enrollment
- 508
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.